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Targeting of drugs in medical practice has been
recognized long ago by Paul Ehrlich as a useful means
to reduce unwanted side-effects of therapeutic treat-
ment (1). In drug targeting the aim is to specifically
direct drugs in the body to cells on which they should
act, without interference with other cells. In general the
targeting concept includes three components: a drug, a
carrier for the drug and a homing device. A variety of
carriers has been proposed, of which macromolecules,
erythrocytes, liposomes, nanoparticles, microemul-
sions and albumin spheres (2) have been studied. The
homing device can be constructed of molecules which
are able to recognize determinants on the target cell's
surface. For this purpose immunoglobulins, glycopro-
teins, glycolipids, polypeptides and antigens (2) have
been studied. For use in vivo the carrier-homing device
combinations have to be non-toxic and biodegradable
without giving rise to formation of toxic degradation
products and they should preferably be applicable for a
large variety of drugs including both hydrophobic and
hydrophilic derivatives. Upon reaching the target cells
by means of the carrier-homing device combination,
the drug may exert its action in two possible ways. First-
Iy, it may gradually be released from the carrier bound
on or near the surface of the target cells leading to a
high local drug concentration for a prolonged period
of time and secondly, the carrier with the drug may be
internalized by the target cells giving rise to a high in-
tracellular drug concentration. The first mechanism
can be considered an example of the well-known phar-
macologicai principle of "sustained drug release", but
at the cellular level. For the second mechanism to
become operative it is important to know the
mechanism of uptake of the drug-carrier complex and
its implications for intracellular release of the drug. At
the moment one of the combinations under study is the
system in which liposomes serve as carriers and
glycolipids, immunoglobulins or glycoproteins are us-
ed as homing devices (3, 4).
In this thesis the experimenial part is focused on
Iiposomes with and without glycolipids. By the incor-
poration of naturally occurring glycolipids (lac-
tosylceramide, chapter I, II) or a synthetic one (tris-gal-
chol, chapter III) into liposomes efforts were under-
laken to target the liposomes to the parenchymal cells
of the liver, the hepatocytes. Furthermore, attention
was paid to ihe question whether the liposones do
become internalized and if so. bv what mechanism
(chapter IV) and finally, the influence of the composi-
tion of the (non-glyco)lipids in the liposomal mem-
branes on the targeting to hepatocytes was Studied
(chapter V).
In the following sections of this introduction it will
be explained or discussed
- what liposomes are and how they are prepared;
- what the fate of a liposome could be once it has
reached the plasma membrane of a cell, in particular
the hepatocyte;
- why the hepatocytes were chosen as a target, and
- what the implication of the liver anatomy is for the
availability of liposomes to the various cell types
constituting this organ.
Liposomes
Liposomes are artificial lipid vesicles with diameters
ranging from 25 nm to several microns. They consist of
one or more lipid bilayers enclosing a similar number
of aqueous compartments. The number of lipid
bilayers per vesicle and the diameter can be varied by
applying different preparation techniques (5) and thus
liposomes can be divided into three main classes:
a. small unilamellar vesicles (SUV) with a diameter in
the range of 25-70 nm and consisting of one lipid
bilayer;
b. large unilamellar vesicles (LUV) also bounded by
only one lipid bilayer but with diameters ranging
from 100 to 400 nm;
c. multilamellar vesicles (MLV), composed of two or
more concentric bilayers and ranging in diameter
from 200 nm to several microns.
For reasons which will be made clear in the section
on liver anatomy, we chose to use SUV for the investiga-
tions presented in this thesis. The preparation of such
vesicles will briefly be described. When phospholipids
are dispersed in an aqueous solution, multilamellar
vesicles are spontaneously formed with a mean
diameter in the order of microns. By ultrasonic irradia-
tion (sonication) their size can be reduced and,
ultimately, small unilamellar vesicles are formed.
When a drug is mixed with the lipids or dissolved in the
buffer before sonication it will either be incorporated
into the lipid bilayer (in case of a lipophilic drug) or it
will be trapped in the aqueous compartment of the
vesicles (in case ofa hydrophilic drug). Gel filtration of
the preparation upon sonication can separate any re-
maining larger vesicles and free drug from the SUV
(Fig. l). By pooling the SUV-containing fractions a
SUV preparation without contaminating larger
vesicles or free drug can be obtained. Since this thesis
mainly deals with the in vivo behavior of liposomes
a
after intravenous injection, the possible influence of
blood on the integrity of liposomes has to be taken into
consideration.
In liposomes consisting of one species of
phospholipids only, the lipid bilayer can undergo a
temperature induced transition from a gel phase to a li-
quid crystalline phase. ln the presence of plasma, vesi-
cle integrity is most severely endangered when the
liposomal lipids are near or at the gel to liquid
crystalline phase transition temperature (Ts). Under
these conditions the liposomal membrane, particulary
of SUY is extremely susceptible to the destructive ac-
tion of high-density lipoproteins (6), but also above Ts
SUV are sensitive to these plasma effects. Thus,
phospholipids such as distearoylphosphatidylchol ine
(DSPC) with a Ts of 56'C have been used to prepare
relatively plasma-resistant liposomes (7). Also
cholesterol has been found to protect liposomes from
the solubi l izing effects of the plasma l ipoproteins (8).
Cholesterol tends to t ighten the packing of
phospholipid molecules in a bilayer due to strong rn-
teractions with these lipids; incorporation of 33 molgo
of cholesterol abolishes the phase transition in a
phospholipid bi layer and thus the extreme sensit ivi ty
of liposomes to plasma influences at the Tc,
Cholesterol also reduces the exchange of phospho.
lipids between vesicles and lipoproteins; particulary in
case of sphingomyelin as phospholipid cholesterol ef.
fectively surpresses this phospholipid exchange (8),
Thus radioactive-labeled sphingomyelin is quite
suitable as a lipid label for cholesterol-containing
liposomes in circulation. In our experiments howevcr,
we mainly used the aqueous space marker (3H-)inulin
as a liposomal label. Any inulin (a poly-fructose
molecule with a M1 of r 5000) released from liposomes
in circulation will quickly be excrered by the kidneys,
Because inulin can not be metabolized. the measure.
ment of (3H-)label in a cell or organ yields a good in-
dication of the amount of accumulated l iposomes.
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lysosomal system.
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Endocytosis
Endocytosis is the process of interl
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F ig.  l .  Preparat ion of  smal l  uni lamel lar  l iposomes.
Lipids are thoroughly dried under vacuum. To the resulting
lipid film (A) the aqueous medium containing the solute to be
trapped (:::) is added. Bv dispersion of the lipids large
rnultilamellar liposomes are formed (ts). Ultrasonic irradia-
D
tion by means ofa probe sonifier (C) results iu break down of
the multilamellar structures and the formatiorr ot small
unilaniellar liposomes. By gel filtrarion the Iiposomal
suspension is freed of remaining rnultilamellar liposomes
and unenrrapped solute (D).
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c. the liposomes may be taken up by the cells by an en-
docytic process, delivering the liposomes to the
lysosomal system.
This last event is generally thought to play the most
prominent role in the uptake of liposomal contents by
cells (9, 10, 1l); therefore this process will now be
described in more detail.
Endocytosis
Endocytosis is the process of internalization of ex-
tracellular material by invagination of the plasma-
membrane and the subsequent formation of a
cytoplasmic vesicle. 'Ihis vesicle has been given dif-
ferent names such as phagosome (12), pinosome (13),
coated vesicle (14) or primary food vacuole (15), depen-
ding on the cell type studied and on the type of en-
docytosis involved. Classically, endocytosis has been
divided into two types: phagocytosis, covering the in-
ternalization of particles larger than a few tenths of a
micron in diameter, and pinocytosis describing the up-
take of all smaller substrates, varying from colloidal
particles such as lipoproteins and SUV to low-
molecular weight solutes and to the surrounding fluid.
Phagocytosis ahvays involves adsorption of the parti-
cle to the plasma membrane prior to invagination. Up-
take by pinocytosis can also be adsorptive in character
(adsorptive pinocytosis), but it may also merely involve
internal izat ion of f luid with solutes (f luid pinocytosis).
Adsorptive endocytic processes display saturation
kinetics, whereas uptake by fluid pinocytosis is linearly
proportional to the concentration of the solute. Ad-
sorptive pinocytosis may be preceded by non-specific
binding of the substance to the cel l  surtace or i t  may in-
volve interaction with highly specif ic recognit ion sites
(recepLors) on the cell membrane; this latter
mechanism is known as receptor mediated endocytosis.
For example, polypeptide hormones l ike epidermal
growth factor (16) and insul in (17), plasma l ipoproteins
such as low density l ipoprotein (18), a2-macroglobul in
(19) and asialoglycoproteins (20) are known to be taken
up by receptor-mediated endocytosis. The intracelluiar
fate of receptors and substrates thus internalized
depends on the cel l  type and the nature of the l igand.
For instance, when the Fc-receptor, expressed on the
surface of macrophages, is occupied by a ligand (inr-
munocomplex) both receptor and ligand are degraded
in the lysosomes, whereas internalized unoccupied
receptors are recycled back to the plasma membrane
(21). Receptor recycl ing also occurs in case of the
transferrin receptor (22) but in this case the ligarrd
(transferrin) is recycled together with its receptor back
to the cell surface while the transported iron is delivered
intracellularly. The asialoglycoprotein (ASGP) recep-
tor, after internalization, is uncoupled from its ligand
before the lysosomes are reached, and is recycled to the
cell surface, whereas its ligand ultimately is degraded in
the lysosomes (23). Some aspects of the overall uptake
mechanism are shared by different ligands, but the
ligand-receptor combination is thought to dictate
which divergent path is taken once they are inside the
cell. The ASGP receptor, which is abundant on the
plasma membrane of hepatocytes, binds ligands with
terminal non-reducing galactose residues. Liposomes
which expose such galactose residues, it was reasoned,
could specifically be directed towards the hepatocytes.
L r G A N  D - - REcEpToF o a
E N DOSOM E
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Fig. 2. Pathway of receptors and ligands as determined for galac-
tose terminal glycoproteins.
Ligands bind to receptors diffusely and then collect in coated
pits, which invaginate and are internalized as coated vesicles
whose fusion gives rise to endosomes and then to a CURL. ln
the acidic CURLenvironment ligand is dissociated from
receptors. Ligand accumulates in the vesicular lumen of the
CURL and the receptors are concentrated in the membrane
of an attached tubular structure, which then becomes
separated from the CURL. The vesicular part moves deeper
into the cell and fuses with a lysosome, 1o which it delivers the
ligand for degradation. The membranous tubular structure ls
thought to recycle receptors to the plasma membrane.






The ASGP receptors are probably randomly
distributed in the plasma membrane of the hepatocytes
(24). After binding of a ligand the receptor-ligand com-
plex moves to a so-called coated pit (14), a specialized
region of the plasma membrane, of which the name is
derived from the fuzzy coat that decorates its
cytoplasmic surface. This coat is formed of clathrin
(25,26), a protein which structurally supports (he for-
mation of) the invaginations of the plasma membrane.
In the coated pits microaggregation, and thus concen-
tration, of the receptors takes place (24). Internaliza-
tion is completed by closure of the coated pit, giving
rise to the formation of a coated vesicle (14). The coated
vesicle looses its coat of clathrin molecules and the re-
maining smooth endocytic vesicle fuses with or con-
verts into a so-called compartment of uncoupling
receptor and ligand (CURL) (27,28). Probably due to
acidification of this compartment the receptor and
ligand dissociate (29), followed by spatial segregation.
The receptors are transported back to the cell surface
where they are reutilized and the vesicles containing the
ligands fuse with primary lysosomes (23) where
degradation takes place (Fig. 2).
Liver
The liver is an important organ involved in the
maintenance of homeostasis n the body. It performs a
scala of functions including a regulatory role in the
metabolism of carbohydrates, proteins and lipids and
is involved in detoxification and storage. It regulates
blood glucose concentration and synthesizes and
eliminates almost all plasma proteins. Participation of
the liver in lipid metabolism involves for example the
regulation of the blood cholesterol level, the synthesis
from carbohydrates of triglycerides for assembly into
lipoproteins and the synthesis of apolipoproteins for
the transport of triglycerides in the blood; it also syn-
thesizes the phospholipids required for lipoprotein for-
mation and for the production of bile. Most of the
metabolic liver functions are performed by the paren-
chymal iver cell or hepatocyte, the most abundant cell
type in the liver. Several pathological conditions are the
result of interference with the hepatocyte's metabolism
e.g. by parasites or viruses or malignant transforma-
tion. These considerations constituted a major argu-
ment for choosing the hepatocyte as a target for the
deiivery of drug-containing liposomes. In addition, the
liver is one of the few organs with an architecture allow-
ing liposomes to escape from the vascular system and
to reach cells beyond the endothelial barrier. As
pointed out by Postg discussing the problems and op-
portunities of liposome targeting in vivo (10),
liposomes injected intravenously are otherwise unlike.
ly to escape from the continuous capillaries and to
reach extravascular tissue.
The features of the hepatic blood circulation and
microanatomy that allow liposomes to reach the
hepatocytes will now briefly be discussed. The blood
supply of the mammalian liver is provided by two
afferent vessels: the hepatic artery, which deliven
oxygen-rich blood and the portal vein, whicl
transports substances absorbed from the
gastrointestinal tract to the liver. Both the hepatic
artery and the portal vein have numerous branches
within the liver, with successive branches having
smaller diameters. The terminal branches are called
sinusoids and there venous and arterial blood come
together. Extensive exchange of materials and
metabolites between blood and liver cells occurs in the
sinusoids. After passage through the sinusoids, the
blood is collected in branches ofthe hepatic veins, con.
verging in the vena hepatica, which drains on the in.
ferior vena cava,
In addition to the hepatocytes the liver contains three
other cell types: Kupffer cells (liver macrophages), the
sinusoidal endothelial cells and the fat-storing cells
(30). Each of these cells is found at specific locations in
the sinusoid (Fig. 3), which measures about 6-7;r in
diameter. The endothelial cells form the linins of the
Fig. 3. Scheme of a liver sinusoid.
Endothelial cell (EC); Kupffer cell (KC); parenchymal cell
(PC); space of Disse (SD); Fat-Storing Cell (FSC); lipid
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